Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
Author(s) -
Jessica Bazick,
Michele Donithan,
Brent A. NeuschwanderTetri,
David E. Kleiner,
Elizabeth M. Brunt,
Laura Wilson,
Ed Doo,
Joel E. Lavine,
James Tonascia,
Rohit Loomba
Publication year - 2015
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc14-1239
Subject(s) - medicine , nonalcoholic fatty liver disease , diabetes mellitus , type 2 diabetes , gastroenterology , fatty liver , fibrosis , insulin resistance , disease , obesity , endocrinology
Approximately 18 million people in the U.S. have coexisting type 2 diabetes and nonalcoholic fatty liver disease (NAFLD). It is not known who among these patients has nonalcoholic steatohepatitis (NASH) with advanced fibrosis. Therefore, we aimed to determine factors that are associated with both NASH and advanced fibrosis in patients with diabetes and NAFLD in order to identify who should be prioritized for referral to a hepatologist for further diagnostic evaluation and treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom